Your browser doesn't support javascript.
loading
Keratolysis exfoliativa-like eruption induced by ranolazine.
Pierobon, Elena; Germi, Lerica; Sechi, Andrea; Trevisan, Giampaolo; Pezzolo, Elena; Feliciani, Claudio; Naldi, Luigi.
Afiliação
  • Pierobon E; Section of Dermatology, Department of Medicine and Surgery, University of Parma.
  • Germi L; Dermatology Unit, San Bortolo Hospital, Vicenza, Italy.
  • Sechi A; Dermatology Unit, San Bortolo Hospital, Vicenza, Italy.
  • Trevisan G; Dermatology Unit, San Bortolo Hospital, Vicenza, Italy.
  • Pezzolo E; Dermatology Unit, San Bortolo Hospital, Vicenza, Italy.
  • Feliciani C; Section of Dermatology, Department of Medicine and Surgery, University of Parma.
  • Naldi L; Dermatology Unit, San Bortolo Hospital, Vicenza, Italy.
Dermatol Reports ; 14(1): 9264, 2022 Mar 11.
Article em En | MEDLINE | ID: mdl-35399369
ABSTRACT
Dermatoses affecting palms may represent a dermatologic challenge from both the diagnostic, and therapeutic point of view. Patients with supposedly occupational dermatitis can spend months or even years in a frustrating attempt to avoid contact with possible irritants or allergens. To underline the importance of a thorough unbiased analysis of the patient's history and clinical features, we present the iconic case of a bricklayer affected by a chronic, disabling desquamation of palms which in the end was classified as keratolysis exfoliativa (KE) attributed to ranolazine-intake, an antianginal drug. To the best of our knowledge, this specific adverse effect of druginduced KE of palms has never been reported before in association with ranolazine.
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Idioma: En Ano de publicação: 2022 Tipo de documento: Article